Related Experiment Video

Updated: Feb 16, 2026

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
07:13

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

Published on: April 30, 2020

6.9K

Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart

Bin Tang1,2, Jin-Guo Zhang3, Hong-Yong Tan1

  • 1Department of Cardiology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272000, China.

Bioscience Reports
|January 6, 2018
PubMed

Insights

Astragaloside IV (AS-IV) improves heart function in chronic heart failure (CHF) rats by reducing ventricular remodeling and enhancing energy metabolism. This natural compound shows therapeutic potential for CHF patients.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Biochemistry

Background:

  • Chronic heart failure (CHF) is a severe cardiovascular condition characterized by ventricular remodeling.
  • Inhibiting ventricular remodeling is a key therapeutic strategy for CHF.
  • Astragaloside IV (AS-IV) is known to improve cardiac function and protect myocardial cells.

Purpose of the Study:

  • To investigate the effects of AS-IV on ventricular remodeling in a rat model of CHF.
  • To explore AS-IV's role in regulating cardiac energy metabolism in CHF.
  • To assess AS-IV's impact on key proteins involved in fatty acid metabolism.

Main Methods:

  • A rat model of CHF was established and treated with AS-IV (low and high doses) or benazepril hydrochloride for 8 weeks.
  • Cardiac structure and function were assessed using echocardiography and histological analysis.
  • Protein and mRNA expression of PPARα, MCAD, and MCPT1 were analyzed.

Main Results:

  • CHF rats exhibited increased left ventricular mass index (LVMI), collagen volume fraction (CVF), and free fatty acid (FFA) concentration.
  • Expression of PPARα, MCAD, and MCPT1 was decreased in CHF rats.
  • AS-IV treatment improved cardiac function and structure, increased PPARα, MCAD, and MCPT1 expression, and enhanced FFA utilization.

Conclusions:

  • AS-IV effectively inhibits ventricular remodeling and improves cardiac function in a rat model of CHF.
  • AS-IV enhances cardiac energy metabolism by upregulating key proteins involved in FFA utilization.
  • AS-IV demonstrates significant therapeutic potential for treating chronic heart failure.

Keywords:
Astragaloside IVchronic heart failureenergy metabolismfree fatty acidratventricular remodeling

More Related Videos

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

14.0K
Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation08:43

Chronic Ovine Model of Right Ventricular Failure and Functional Tricuspid Regurgitation

Published on: March 17, 2023

1.1K

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
431
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
966
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
593
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.3K